Free tool
Oncology stocks
We cover 26 companies grouped under the Oncology theme. The median market value in the group is $44.51M. Across the group, the median move over the past trading day is 0.00%. 28% of the 25 with a 200-day average trade above it. Price change over the past year runs from −73.7% to +29.7% across the middle 80 percent of the group, with a median of −29.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
26 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +3.46% |
| 4888.T | Stella Pharma Corporation | $80.24M | Micro cap | −11.75% |
| 4564.T | OncoTherapy Science, Inc. | $56.36M | Micro cap | −25.00% |
| ATX.AX | Amplia Therapeutics Limited | $54.23M | Micro cap | −14.71% |
| IMM.AX | Immutep Limited | $54.01M | Micro cap | −79.18% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| PTX.AX | Prescient Therapeutics Limited | $50.63M | Micro cap | +63.41% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.19M | Micro cap | −39.08% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.76% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −5.56% |
| SNT.AX | Syntara Limited | $38.09M | Micro cap | +1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | $33.98M | Micro cap | −59.32% |
| 4582.T | SymBio Pharmaceuticals Limited | $31.19M | Micro cap | −57.43% |
| IMU.AX | Imugene Limited | $25.70M | Micro cap | −75.00% |
| NOX.AX | Noxopharm Limited | $19.87M | Micro cap | −10.00% |
| 4882.T | Perseus Proteomics Inc. | $17.25M | Micro cap | −56.56% |
| RAD.AX | Radiopharm Theranostics Limited | $16.95M | Micro cap | −63.64% |
| 4598.T | Delta-Fly Pharma, Inc. | $9.28M | Micro cap | −81.75% |
| PER.AX | PERCHERON FPO [PER] | $5.45M | Micro cap | −54.55% |
| IVX.AX | Invion Limited | $2.83M | Micro cap | −72.31% |
| NX1.AX | Nexalis Therapeutics Limited | $2.00M | Micro cap | −50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.